Correlation Between Vigil Neuroscience and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Vigil Neuroscience and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Verrica Pharmaceuticals.
Diversification Opportunities for Vigil Neuroscience and Verrica Pharmaceuticals
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Vigil and Verrica is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vigil Neuroscience and Verrica Pharmaceuticals
Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Verrica Pharmaceuticals. In addition to that, Vigil Neuroscience is 1.0 times more volatile than Verrica Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about 0.0 per unit of volatility. If you would invest 318.00 in Verrica Pharmaceuticals on August 27, 2024 and sell it today you would lose (218.00) from holding Verrica Pharmaceuticals or give up 68.55% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Vigil Neuroscience vs. Verrica Pharmaceuticals
Performance |
Timeline |
Vigil Neuroscience |
Verrica Pharmaceuticals |
Vigil Neuroscience and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vigil Neuroscience and Verrica Pharmaceuticals
The main advantage of trading using opposite Vigil Neuroscience and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.Vigil Neuroscience vs. Eliem Therapeutics | Vigil Neuroscience vs. HCW Biologics | Vigil Neuroscience vs. Scpharmaceuticals | Vigil Neuroscience vs. Milestone Pharmaceuticals |
Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |